Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
189.00    -3.60 (-1.87%)
Bid:
189.20
Ask:
190.60
Spread: 1.40 (0.74%)
Market Cap: £504.78m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Director/PDMR Shareholding

7 Apr 2016 07:00

RNS Number : 4131U
Costain Group PLC
07 April 2016
 

Costain Group PLC("Costain" or "the Company")

The following notification is made in accordance with DTR 3.1.4R (1) (a).

 

Costain Group PLC announces the following grant of share awards to certain directors of the Company under the Share Deferral Plan and the Company's Long Term Incentive Plan as detailed in sections (A) and (B) below.

(A) Costain Group PLC 2014 Share Deferral Plan

 

On 06 April 2016, awards over ordinary shares of 50p each in the Company were made under the Costain Group PLC 2014 Share Deferral Plan (the "Share Deferral Plan").

 

The awards granted under the Share Deferral Plan are structured as options with a nil exercise price over a number of shares (the "Awards"). No consideration was paid for the grant of the Awards.

Awards were made to the following Executive Directors:

Name of Director

Number of Shares Under the Awards

Andrew Wyllie

51,643

Anthony Bickerstaff

34,428

 

The Awards will become exercisable on or around the second anniversary of the date of grant subject to the Rules of the Share Deferral Plan and the continued employment of the participants. To the extent that all or any part of the Awards become exercisable, they will remain exercisable until the day before the tenth anniversary of the date of grant provided the individual remains an employee or officer of the Company.

 

(B) Costain Group PLC 2014 Long Term Incentive Plan

On 06 April 2016, awards under the Costain Group PLC 2014 Long Term Incentive Plan (the "LTIP") were made over ordinary shares of 50p each in the Company in the form of nil-cost options (the "Awards").

No consideration was paid for the grant of the Awards.

The vesting of the Awards is subject to the satisfaction of certain performance conditions. The Annual Report 2015 included proposed performance conditions. The performance conditions have now been finalised by the Remuneration Committee of the Company and are as follows: an EPS target of 91.7p (for 15% vesting) and 101.7p (for 100% vesting), with vesting on a straight-line basis between the two. 50% of the Awards will normally vest three years after grant, subject to the satisfaction of performance conditions over the three year financial period ending 31 December 2018, whilst the remaining 50% of the Awards will normally vest on the fifth anniversary of the date of grant (with no further performance conditions required). The Awards will remain exercisable from the date of vesting of each half of the Awards until the day before the tenth anniversary of the date of grant provided the individual remains an employee or officer of the Company.

Awards were made to the following Executive Directors:

Name of Director

Number of Shares subject to the Award

Andrew Wyllie

132,678

Anthony Bickerstaff

87,913

The Company was informed of the above transactions on 06 April 2016.

 

07 April 2016

Enquiries:

Costain Group PLC Tel: 01628 842444Tracey Wood

Company Secretary

 

Instinctif Partners

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSEFIMFMSEDL
Date   Source Headline
9th Jun 20263:25 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSCostain wins place on £700m TfL framework
3rd Jun 202610:30 amRNSTransaction in Own Shares
1st Jun 202610:31 amRNSTotal Voting Rights
27th May 20269:34 amRNSTransaction in Own Shares
22nd May 20261:00 pmRNSDirector/PDMR Shareholding
20th May 20269:55 amRNSTransaction in Own Shares
18th May 20261:51 pmRNSAdditional Listing
18th May 20269:39 amRNSDirector Declaration
14th May 20264:28 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
13th May 20265:14 pmRNSHolding(s) in Company
13th May 202610:19 amRNSTransaction in Own Shares
12th May 20264:01 pmRNSHolding(s) in Company
6th May 20269:35 amRNSTransaction in Own Shares
5th May 20262:08 pmRNSDirector/PDMR Shareholding
1st May 20264:08 pmRNSScrip Dividend Reference Price - Replacement
1st May 20269:08 amRNSTotal Voting Rights
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
29th Apr 202610:14 amRNSTransaction in Own Shares
27th Apr 202612:27 pmRNSScrip Dividend Reference Price
22nd Apr 20265:06 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:48 amRNSTransaction in Own Shares
21st Apr 20265:15 pmRNSHolding(s) in Company
16th Apr 20264:59 pmRNSHolding(s) in Company
15th Apr 20263:16 pmRNSTransaction in Own Shares
15th Apr 20263:05 pmRNSDirector/PDMR Shareholding
14th Apr 20263:29 pmRNSDirector Declaration
13th Apr 202611:20 amRNSDirector/PDMR Shareholding
8th Apr 202610:30 amRNSTransaction in Own Shares
2nd Apr 202611:19 amRNSAnnual Financial Report
1st Apr 202610:30 amRNSTransaction in Own Shares
1st Apr 20269:30 amRNSDirector/PDMR Shareholding
1st Apr 20268:59 amRNSTotal Voting Rights
27th Mar 20263:35 pmRNSAdditional Listing
25th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNS-RCostain Secures c.£45m Contract with Severn Trent
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
4th Mar 20268:27 amRNSDirectorate change
3rd Mar 202610:57 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSCostain returns to FTSE 250
25th Feb 20266:00 pmRNSAshtead Group
24th Feb 20263:59 pmRNSDirector Declaration
23rd Feb 20262:59 pmRNSHolding(s) in Company
20th Feb 20264:19 pmRNSHolding(s) in Company
18th Feb 20261:55 pmRNSHolding(s) in Company
9th Feb 20262:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.